1-12 of 12
Yijun Yang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase 2 March Study: ATG-010 Plus Low Dose Dexamethasone in Chinese Relapsed/Refractory Multiple Myeloma (RRMM) Patients Previously Treated with an Immunomodulatory Agent (IMiD) and a Proteasome Inhibitor (PI)

Lugui Qiu, Weijun Fu, Zhongjun Xia, Zhengzheng Fu, Wenming Chen, Chunkang Chang, Baijun Fang, Gang An, Yongqiang Wei, Zhen Cai, Sujun Gao, Jianyu Weng, Lijuan Chen, Hongmei Jing, Li Fei, Zhuogang Liu, Xiequn Chen, Jing Liu, Yang Yu, Aihua Wang, Yijun Yang, Zhinuan Yu, Kevin Lynch
Journal: Blood
Blood (2021) 138 (Supplement 1): 4770.
https://doi.org/10.1182/blood-2021-145282
Published: 2021
Journal Articles

ATG-010 Plus Low-Dose Dexamethasone (Sd) in Chinese Relapsed/Refractory Multiple Myeloma (RRMM) Patients Previously Received Chimeric Antigen Receptor T-Cell (CAR-T)

Weijun Fu, Lugui Qiu, Zhongjun Xia, Zhengzheng Fu, Wenming Chen, Chunkang Chang, Baijun Fang, Gang An, Yongqiang Wei, Zhen Cai, Sujun Gao, Jianyu Weng, Lijuan Chen, Hongmei Jing, Li Fei, Zhuogang Liu, Xiequn Chen, Jing Liu, Yang Yu, Aihua Wang, Zhinuan Yu, Yijun Yang, Kevin Lynch
Journal: Blood
Blood (2021) 138 (Supplement 1): 4778.
https://doi.org/10.1182/blood-2021-146784
Published: 2021
Journal Articles

Long Term Follow up after Adoptive Transfer of CD19-Specific CAR + T Cells Genetically Modified Via Non-Viral Sleeping Beauty S ystem Following Hematopoietic Stem Cell Transplantation (HSCT)

Partow Kebriaei, MD, Helen Huls, Simon Olivares, Aaron F Orozco, Shihuang Su, Sourindra N Maiti, Elenanor De Groot, Amy Smith, Yijun Yang, PhD, Gabriela Rondon, MD, Muzaffar H. Qazilbash, MD, Stefan O. Ciurea, Amin M. Alousi, Yago Nieto, MD PhD, David Costa Marin, MD, Uday Popat, MD, Chitra Hosing, MD, Hagop M. Kantarjian, MD, Katayoun Rezvani, MD PhD, Elizabeth J Shpall, MD, Richard E Champlin, MD, Laurence J N Cooper, MDPhD, Harjeet Singh, MSc, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2059.
https://doi.org/10.1182/blood.V130.Suppl_1.2059.2059
Published: 2017
Journal Articles

Bone Marrow Stromal Cells Induce Bortezomib Resistance in Multiple Myeloma Cells through Downregulation of miRNA-101-3p Targeting Survivin

Jahangir Abdi, PhD, Yijun Yang, PhD, Patrick Meyer-Erlach, Hong Chang, MD PhD
Journal: Blood
Blood (2015) 126 (23): 1772.
https://doi.org/10.1182/blood.V126.23.1772.1772
Published: 2015
Journal Articles

Tumor Suppressor Microrna-29a/b and Microrna-34a Mediate Small Molecule PRIMA-1 Met -Induced Aoptosis In Multiple Myeloma Cells By Targeting c-Myc

Manujendra N. Saha, Yijun Yang, Hong Chang
Journal: Blood
Blood (2013) 122 (21): 1919.
https://doi.org/10.1182/blood.V122.21.1919.1919
Published: 2013
Journal Articles

Novel Targeting Of Phospho-Marcks Overcomes Drug Resistance and Induces Anti-Tumor Activity In Preclinical Models Of Multiple Myeloma

Yijun Yang, Manujendra N Saha, Yan Chen, Lugui Qiu, MD, Donna E Reece, MD, FRCPC, Hong Chang
Journal: Blood
Blood (2013) 122 (21): 282.
https://doi.org/10.1182/blood.V122.21.282.282
Published: 2013
Journal Articles

Mir-137 and Mir-197 within Chromosome 1p Minimal Deletion Region Regulate Apoptotic Activity in Multiple Myeloma by Targeting MCL 1

Yijun Yang, Venus Onay, Connie Qi, Manujendra N Saha, Yi Ning, Hong Chang
Journal: Blood
Blood (2012) 120 (21): 322.
https://doi.org/10.1182/blood.V120.21.322.322
Published: 2012
Journal Articles

Small Molecule MIRA-1 Induces p53-Independent Apoptosis in Multiple Myeloma Cells Through Activation of the p38 MAPK Signaling Pathway.

Manujendra N Saha, Hua Jiang, Yijun Yang, Donna Reece, Hong Chang
Journal: Blood
Blood (2012) 120 (21): 2937.
https://doi.org/10.1182/blood.V120.21.2937.2937
Published: 2012
Journal Articles

Targeting p53 Via JNK Pathway: A Novel Role of RITA for Apoptotic Signaling in Multiple Myeloma

Manujendra N Saha, Hua Jiang, Yijun Yang, Xiaoyun Zhu, Xiaoming Wang, Aaron D Schimmer, Hong Chang
Journal: Blood
Blood (2011) 118 (21): 1836.
https://doi.org/10.1182/blood.V118.21.1836.1836
Published: 2011
Journal Articles

MARCKS Confers Resistance to Velcade Through Skp2/p27-Mediated Pathway in Multiple Myeloma

Yijun Yang, Johann Micallef, Hong Chang
Journal: Blood
Blood (2011) 118 (21): 985.
https://doi.org/10.1182/blood.V118.21.985.985
Published: 2011
Journal Articles

ACE-011, a Soluble Activin Receptor Type Iia IgG-Fc Fusion Protein, Increases Hemoglobin (Hb) and Improves Bone Lesions in Multiple Myeloma Patients Receiving Myelosuppressive Chemotherapy: Preliminary Analysis.

Kudrat M. Abdulkadyrov, M.D., Ph.D., Galina N. Salogub, M.D., Ph.D., Nuriet K. Khuazheva, M.D., Ph.D., Rachel Woolf, Eric Haltom, Niels G. Borgstein, MD, Robert Knight, MD, Gary Renshaw, DO, Yijun Yang, Matthew L. Sherman, MD
Journal: Blood
Blood (2009) 114 (22): 749.
https://doi.org/10.1182/blood.V114.22.749.749
Published: 2009
Journal Articles

ACE-011, a Soluble Activin Receptor Type IIa IgG-Fc Fusion Protein, Increases Hemoglobin and Hematocrit Levels in Postmenopausal Healthy Women

Kenneth T Kim, MD, Niels G Borgstein, MD, Yijun Yang, Eric Haltom, Louisa Mook, Michelle D Ababa, MD, Sandeep K Reddy, MD, Matthew Leigh Sherman, MD
Journal: Blood
Blood (2008) 112 (11): 3866.
https://doi.org/10.1182/blood.V112.11.3866.3866
Published: 2008